Global Orthostatic Hypotension Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 2049

Orthostatic hypotension, also known as postural hypotension, is a state of dizziness that is caused due to low blood pressure. This is commonly happen when a person stands up from a long sitting and feel dizziness. Orthostatic hypotension can be caused due to heart problems, dehydration, endocrine problems and nervous system disorders.
The orthostatic hypotension disorder is mostly common in the elderly, teenagers and postpartum mothers. The key drivers that can boost the orthostatic hypotension market are increasing in the aging population with increase in the prevalence of diabetes and heart disorders along with availability of increasing number of treatments options. Increasing adoption and integration of technologies in healthcare premises along with emergence of new entrants in the existing market is expected to further propel the demand for treatment of orthostatic hypotension worldwide.
Availability of variety of antihypertensive agents for the treatment of orthostatic hypotension is expected to drive the global orthostatic hypotension treatment market. Innovative treatment and diagnostic options are expected to contribute in the growth of orthostatic hypotension market in the forecast period. Among the available drugs for treatment fludrocortisone is used widely to increase the amount of fluid containing in the blood which would contribute for the increased market share of orthostatic hypotension market.
North America dominates the global orthostatic hypotension market followed by Europe, Japan and Asia Pacific.
In 2018, the global Orthostatic Hypotension market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Orthostatic Hypotension status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Orthostatic Hypotension development in United States, Europe and China.

The key players covered in this study
Mylan
Roche
Upsher-Smith Laboratories
Chelsea Therapeutics
Amgen
Apotex
...

Market segment by Type, the product can be split into
ECG
Blood Tests
Stress Test
Echocardiogram

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Orthostatic Hypotension status, future forecast, growth opportunity, key market and key players.
To present the Orthostatic Hypotension development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Orthostatic Hypotension are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Orthostatic Hypotension Market Size Growth Rate by Type (2014-2025)
1.4.2 ECG
1.4.3 Blood Tests
1.4.4 Stress Test
1.4.5 Echocardiogram
1.5 Market by Application
1.5.1 Global Orthostatic Hypotension Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Orthostatic Hypotension Market Size
2.2 Orthostatic Hypotension Growth Trends by Regions
2.2.1 Orthostatic Hypotension Market Size by Regions (2014-2025)
2.2.2 Orthostatic Hypotension Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Orthostatic Hypotension Market Size by Manufacturers
3.1.1 Global Orthostatic Hypotension Revenue by Manufacturers (2014-2019)
3.1.2 Global Orthostatic Hypotension Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Orthostatic Hypotension Market Concentration Ratio (CR5 and HHI)
3.2 Orthostatic Hypotension Key Players Head office and Area Served
3.3 Key Players Orthostatic Hypotension Product/Solution/Service
3.4 Date of Enter into Orthostatic Hypotension Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Orthostatic Hypotension Market Size by Type (2014-2019)
4.2 Global Orthostatic Hypotension Market Size by Application (2014-2019)

5 United States
5.1 United States Orthostatic Hypotension Market Size (2014-2019)
5.2 Orthostatic Hypotension Key Players in United States
5.3 United States Orthostatic Hypotension Market Size by Type
5.4 United States Orthostatic Hypotension Market Size by Application

6 Europe
6.1 Europe Orthostatic Hypotension Market Size (2014-2019)
6.2 Orthostatic Hypotension Key Players in Europe
6.3 Europe Orthostatic Hypotension Market Size by Type
6.4 Europe Orthostatic Hypotension Market Size by Application

7 China
7.1 China Orthostatic Hypotension Market Size (2014-2019)
7.2 Orthostatic Hypotension Key Players in China
7.3 China Orthostatic Hypotension Market Size by Type
7.4 China Orthostatic Hypotension Market Size by Application

8 Japan
8.1 Japan Orthostatic Hypotension Market Size (2014-2019)
8.2 Orthostatic Hypotension Key Players in Japan
8.3 Japan Orthostatic Hypotension Market Size by Type
8.4 Japan Orthostatic Hypotension Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Orthostatic Hypotension Market Size (2014-2019)
9.2 Orthostatic Hypotension Key Players in Southeast Asia
9.3 Southeast Asia Orthostatic Hypotension Market Size by Type
9.4 Southeast Asia Orthostatic Hypotension Market Size by Application

10 India
10.1 India Orthostatic Hypotension Market Size (2014-2019)
10.2 Orthostatic Hypotension Key Players in India
10.3 India Orthostatic Hypotension Market Size by Type
10.4 India Orthostatic Hypotension Market Size by Application

11 Central & South America
11.1 Central & South America Orthostatic Hypotension Market Size (2014-2019)
11.2 Orthostatic Hypotension Key Players in Central & South America
11.3 Central & South America Orthostatic Hypotension Market Size by Type
11.4 Central & South America Orthostatic Hypotension Market Size by Application

12 International Players Profiles
12.1 Mylan
12.1.1 Mylan Company Details
12.1.2 Company Description and Business Overview
12.1.3 Orthostatic Hypotension Introduction
12.1.4 Mylan Revenue in Orthostatic Hypotension Business (2014-2019)
12.1.5 Mylan Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Orthostatic Hypotension Introduction
12.2.4 Roche Revenue in Orthostatic Hypotension Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Upsher-Smith Laboratories
12.3.1 Upsher-Smith Laboratories Company Details
12.3.2 Company Description and Business Overview
12.3.3 Orthostatic Hypotension Introduction
12.3.4 Upsher-Smith Laboratories Revenue in Orthostatic Hypotension Business (2014-2019)
12.3.5 Upsher-Smith Laboratories Recent Development
12.4 Chelsea Therapeutics
12.4.1 Chelsea Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Orthostatic Hypotension Introduction
12.4.4 Chelsea Therapeutics Revenue in Orthostatic Hypotension Business (2014-2019)
12.4.5 Chelsea Therapeutics Recent Development
12.5 Amgen
12.5.1 Amgen Company Details
12.5.2 Company Description and Business Overview
12.5.3 Orthostatic Hypotension Introduction
12.5.4 Amgen Revenue in Orthostatic Hypotension Business (2014-2019)
12.5.5 Amgen Recent Development
12.6 Apotex
12.6.1 Apotex Company Details
12.6.2 Company Description and Business Overview
12.6.3 Orthostatic Hypotension Introduction
12.6.4 Apotex Revenue in Orthostatic Hypotension Business (2014-2019)
12.6.5 Apotex Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details